Imatinib
matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit (IC50: 600/100/100 nM).
| Catalog Number | T6230 |
| Alternative Name(s) | STI571 , CGP057148B , ST-1571 |
| Research Area | Autophagy|||Microbiology/Virology|||Angiogenesis|||Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling |
| Molecular Formula | C29H31N7O |
| CAS# | 152459-95-5 |
| Purity | 99.51% |
| SMILES | CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Imatinib |
| Additional Information | https://www.targetmol.com/datasheet/T6230 |